Articles Mentioning Life Sciences Tools and Services Stocks

Results 21 - 30 of 379 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Life Sciences Tools and Services

Investing | January 15, 2014

3 Ways the $1,000 Human Genome Can Revolutionize Science and Medicine As We Know It

The cost to sequence a full human genome reached a critical milestone on Tuesday when Illumina announced its next-generation system will enable $1,000 tests. There are far-reaching implications for human health, but the possibilities extend beyond the doctor's office.

Investing | December 07, 2013

How 23andMe Can Spur Growth for These Diagnostics Companies

Direct-to-consumer genetic tests took a hit when the Food and Drug Administration told 23andMe to stop marketing its product. However, accepting the arrival of accessible genetic information could ignite growth opportunities for Myriad Genetics, Genomic Health, and Quest Diagnostics.

Investing | December 06, 2013

Why Selling CROs Like Parexel May Be Short-Sighted

Contract Researchers have taken it on the chin following Parexel's (PRXL) lackluster quarterly results. But that view might be short sighted given drug makers are increasingly turning to CROs to usher drugs through trials.

Investing | November 05, 2013

Why Did This Genetic Test Maker Outperform Its Industry Peers?

Shares of Affymetrix have been on fire over the past year despite lacking any real fundamental fuel. Will this hot stock keep rising, or is it destined to crash and burn?

Investing | October 31, 2013

Why Sequenom Inc. Shares Plunged

An unexpected court ruling crushes Sequenom. Is this bad news or the buying opportunity investors have been waiting for?

Investing | October 26, 2013

1 Huge Growth Market You've Probably Overlooked

Diagnostics have been taking off around health care, from fast risers like Illumina to tried-and-true companies like Thermo-Fisher. Don't miss out on this health boom.

Investing | October 26, 2013

3 Humongous Health-Care Stocks This Week

Which health-care stocks knocked the ball out of the park this week? These three companies scored double-digit gains.

Investing | September 28, 2013

This Week in Biotech

An EU approval for an HIV therapy enhancing drug, mixed late-stage reviews for another big pharmaceutical company, and a rough week for two biotech standouts are this week's top stories.

Investing | September 28, 2013

3 Humongous Health-Care Stocks This Week

How about a 50% gain in one week? That's the worst performance among these health-care high flyers.

Investing | September 26, 2013

What Was Behind Pacific Biosciences' 70% Pop?

The details behind Roche's deal with Pacific Biosciences of California.

Results 21 - 30 of 379 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Life Sciences Tools and Services